As of 2024-12-14, the Fair Value of Poseida Therapeutics, Inc. (PSTX) is -3.12 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.51 USD, the upside of Poseida Therapeutics, Inc. is -132.77%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -86.50 | -129.80 | -125.00 | -64.00 | -123.43 | -105.75 |
| YoY growth | -94.82% | -50.06% | 3.70% | 48.80% | -92.86% | -37.05% |
| Market Cap (mil) | 926.94 |
| P/E | |
| Forward P/E |
| EPS | -0.62 |
| Avg earnings growth rate | -37.05% |
| TTM earnings | -60.76 |